Fundamental Analysis
63 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +271.9% | +650.1% | 2 / 3 | +65.8% | -0.43 pp | +3.10 pp | +7.2% | 1.56 | 9.24 | 471 | +65,8% | 8,4 | +324,7% | 9.24 | 18.80 | −50,9% |
| Pts | 12 | 12 | 8 | 12 | 4 | 12 | 0 | -4 | 12 | |||||||
Valuation annotation:Price: 7.150 (close price on 2026-10-19)EPS (TTM): 774,2
Financial charts
1.Revenue & growth
VND bn471Q2/26
1.Revenue & growth
VND bn471Q2/26
2.Profit & growth
VND bn7,90Q2/26
3.Profit mix (Penman)
VND bn51,7Q2/26
4.Margins & cost structure
%6.3%Q2/26
5.Returns & cash cycle
% · days-1.1%Q2/26
6.Earnings quality & cash
VND bn-364Q2/26
7.Asset structure
VND bn1.942Q2/26
8.Funding & debt health
VND bn · times1.942Q2/26
9.Revenue backlog
VND bn214Q2/26
10.Valuation
times · %9,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %222Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
839%
averaged over 2 quarter(s)
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26